NASDAQ:BIOR

Biora Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy BIOR

*Your capital is at risk

$0.220

+0 (+0%)

At Close: Nov 17, 2025

Biora Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -96.98. In total, the insiders bought 138.38M and sold 223.8M BIOR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-96.98
● Buy	138.38M shares
● Sell	223.8M shares
74% Buy Activity Weak Positive Correlation
Buy Signal Low Confidence Nov 17, 2025 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -96.98. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 12, 2024 Buy	11.00% / 13.00% Convertible Senior Secured Notes due 2028 A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Dec 12, 2024 Buy	11.00% / 13.00% Convertible Senior Secured Notes due 2028 A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Aug 15, 2024 Sell	Common Stock F-InKind	Mohanty Aditya P. Chief Executive Officer	CEO / President	70 883 Value: $47.5K
Aug 15, 2024 Sell	Common Stock F-InKind	Neumann Clarke See Remarks	Officer	26 629 Value: $17.8K
Aug 15, 2024 Sell	Common Stock F-InKind	Desparbes Eric Chief Financial Officer	C-Suite Officer	27 830 Value: $18.6K
Aug 15, 2024 Sell	Common Stock F-InKind	Desparbes Eric Chief Financial Officer	C-Suite Officer	27 830 Value: $18.6K
Aug 15, 2024 Sell	Common Stock F-InKind	Neumann Clarke See Remarks	Officer	26 629 Value: $17.8K
Aug 15, 2024 Sell	Common Stock F-InKind	Mohanty Aditya P. Chief Executive Officer	CEO / President	70 883 Value: $47.5K
Aug 12, 2024 Buy	Warrant A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	5 039 236 Value: $3.02M
Aug 12, 2024 Buy	Warrant A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	2 085 372 Value: $1.25M
Aug 12, 2024 Buy	Warrant A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	500 249 Value: $300.1K
Aug 12, 2024 Buy	Warrant A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	457 250 Value: $274.4K
Aug 12, 2024 Buy	Warrant A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	323 886 Value: $194.3K
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	2 085 372 Value: $10.4M
Aug 12, 2024 Buy	11.00%/13. 00% Convertible Senior Secured Notes due 2028 A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Aug 12, 2024 Sell	11.00%/13. 00% Convertible Senior Secured Notes due 2028 D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	457 250 Value: $288.1K
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	5 039 236 Value: $27.7M
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	500 249 Value: $4.11M
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	500 249 Value: $4.11M
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	5 039 236 Value: $27.7M
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	457 250 Value: $288.1K
Aug 12, 2024 Sell	11.00%/13. 00% Convertible Senior Secured Notes due 2028 D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Aug 12, 2024 Buy	11.00%/13. 00% Convertible Senior Secured Notes due 2028 A-Award	Athyrium Opportunities Iii Co-invest 1 Lp	Director	0 Value: $0
Aug 12, 2024 Sell	Warrant D-Return	Athyrium Opportunities Iii Co-invest 1 Lp	Director	2 085 372 Value: $10.4M

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIORA THERAPEUTICS, INC.

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enh...

Read Full Profile Here